In the context of the escalating significance of ANO7 and SLC38A4 as promising and innovative prognostic, immunomodulatory, and therapeutic biomarkers in CRC, we conducted a comprehensive analysis of their expression levels in CRC tissues (n = 25) alongside adjacent normal tissues (n = 25) using RT-qPCR. The gene discussed is ANO7; the disease is colorectal carcinoma.